Chiron Real Estate (XRN) Q4 2024 earnings summary

Executive summary

• Portfolio occupancy at 96.4% with a weighted average lease term of 5.6 years and rent coverage ratio of 4.5x as of Q4 2024.

• Net income attributable to common shareholders was $1.4 million ($0.02/share) in Q4 2024, reversing a net loss of $800,000 ($0.01/share) in Q4 2023.

• FFO per share and unit was $0.15 in Q4 2024, down $0.04 year-over-year, mainly due to $3.2 million in severance costs.

• AFFO per share and unit was $0.22 in Q4 2024, nearly flat year-over-year.

• CEO succession plan announced, with transition expected to be seamless; outgoing CEO to remain as Chairman.

Financial highlights

• Total revenues for Q4 2024 increased 6.7% year-over-year to $35.2 million, driven by acquisitions.

• Total expenses for Q4 2024 were $36.3 million, up from $31.5 million in Q4 2023, due to one-time CEO transition costs.

• Q4 2024 rental revenue increased 6.1% year-over-year to $35.0 million.

• G&A expenses rose to $7.7 million in Q4 2024, primarily from $3.2 million in CEO succession costs.

• Aggregate gain of $5.8 million from four property dispositions in Q4 2024.

Outlook and guidance

• 2025 AFFO per share and unit guidance is $0.89–$0.93, excluding CEO transition costs.

• Guidance assumes no additional acquisitions/dispositions beyond those announced and no new equity/debt issuances except normal revolver activity.

• Projected 2025 capital expenditures of $12–$14 million.

• G&A expenses in 2025 (excluding CEO transition) expected to be $4.5–$4.7 million per quarter.

• Rent at the Beaumont, TX facility expected to commence in Q2 2025 under a new 15-year lease with CHRISTUS Health.